Pharmaceuticals News
Press Releases from Pharmaceuticals Companies
Newsroom
Pharmaceuticals news releases from pharmaceuticals companies published by Newsfile. Searches will return results from stories up to two years old.
-
Hemostemix' "Your Fountain of Youth" Trademark Granted by Japan Patent Office
Calgary, Alberta--(Newsfile Corp. - January 26, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the Japan Patent Office issued Kwalata Trading Limited, a wholly owned subsidiary of Hemostemix Inc., a trademark registration certificate for Your Fountain of Youth. "Your...
Biotechnology, Pharmaceuticals, Health
2023-01-26 3:27 PM EST | Hemostemix Inc. -
NuGen Medical Devices Announces New Unit Offering and Resignations and Appointment of An Officer and Director
Toronto, Ontario--(Newsfile Corp. - January 26, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") announces that it has closed its previously announced non-brokered private placement of units as described in its press release dated December 28, 2022 for total aggregate proceeds of $125,000. No additional tranches will be...
Healthcare and Hospitals, Pharmaceuticals, Health
2023-01-26 9:00 AM EST | NuGen Medical Devices Inc. -
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
Vancouver, British Columbia--(Newsfile Corp. - January 26, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering and developing patient-focused psychedelic-derived medicines for neurologic and brain disease, today announced that it has signed an Investigator Initiated Research Agreement with...
Technology, Pharmaceuticals, Health
2023-01-26 8:30 AM EST | Lobe Sciences Ltd. -
PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds
Vancouver, British Columbia--(Newsfile Corp. - January 25, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the grant of Australian patent no. 2018305726, titled "Disulfide bond containing compounds and uses thereof," on January 5, 2023. The patent is owned by the University...
Biotechnology, Pharmaceuticals, Health
2023-01-25 7:00 AM EST | PreveCeutical Medical Inc. -
Hemostemix Wins Arbitration Decision
Calgary, Alberta--(Newsfile Corp. - January 24, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the Arbitrator has dismissed Dr. Burchardt's claims for compensation and damages against the Company, set aside the Change of Control Agreement on the grounds that...
Biotechnology, Pharmaceuticals, Health
2023-01-24 9:00 AM EST | Hemostemix Inc. -
Defence's Melanoma Targeted Vaccine A1-Reprogrammed MSC (ARM) Cell Potency Validated
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the validation of its ARM vaccine candidate in...
Biotechnology, Pharmaceuticals, Health
2023-01-24 3:15 AM EST | Defence Therapeutics Inc. -
Award-Winning Agency Absolute Digital Media Scoop Up 2 Awards at UK Digital Excellence Awards to Start the Year
London, United Kingdom--(Newsfile Corp. - January 23, 2023) - Last month Absolute Digital Media, a multi-award-winning digital marketing agency that operates across the United Kingdom and worldwide had been nominated at the prestigious UK Digital Excellence Awards.
Banking/Financial Services, Gambling/Casinos, Pharmaceuticals, Health
2023-01-23 9:45 AM EST | Absolute Digital Media -
Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year Costs
Calgary, Alberta--(Newsfile Corp. - January 23, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it is hiring four new biotechnologists to re-establish the Company's production of ACP-01 in Montreal. The Company is hiring an experienced autologous stem cell therapy Manufacturing...
Biotechnology, Pharmaceuticals, Health
2023-01-23 9:37 AM EST | Hemostemix Inc. -
Global Hemp Group Announces Execution of Exclusive Licensing Agreement for the Intellectual Property of Apollon Formularies PLC Covering the United States, Canada, and Mexico
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that further to the Company's announcement of January 11, 2023 regarding the execution of the binding LOI with Apollon Formularies Plc - (AQSE:
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Cannabis
2023-01-23 9:09 AM EST | Global Hemp Group Inc. -
Lobe Sciences Board of Directors Elects to Receive Shares in Lieu of Cash for All Board Fees
Endorsement underscores transition into a fully integrated biotechnology companyVancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced its Board...
Technology, Pharmaceuticals, Health
2023-01-23 9:00 AM EST | Lobe Sciences Ltd. -
Telescope Presents 2022 Fiscal Year Highlights and Investor Update
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, provides a financial and corporate update.KEY HIGHLIGHTSTelescope generated revenues of CAD $595,398 in its first...
Technology, Chemical, Pharmaceuticals, Psychedelics
2023-01-23 8:00 AM EST | Telescope Innovations Corp. -
PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that US patent no. 11,566,044, titled 'Disulfide bond containing compounds and uses thereof', will be granted on January 31, 2023. The patent is owned...
Biotechnology, Pharmaceuticals, Health
2023-01-23 7:00 AM EST | PreveCeutical Medical Inc. -
RETRANSMISSION: Defence to Present at the 9th Annual Immuno-Oncology 360º Summit in New-York February 7-10, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that Defence will attend, from February 7-10, 2023,...
Biotechnology, Pharmaceuticals, Health
2023-01-23 3:15 AM EST | Defence Therapeutics Inc. -
Defence To Present at The 9th Annual Immuno-Oncology 360 Summit in New-York February 7-10, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 20, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that Defence will attend, from February 7-10, 2023,...
Biotechnology, Pharmaceuticals, Health
2023-01-20 4:30 PM EST | Defence Therapeutics Inc. -
Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation
Calgary, Alberta--(Newsfile Corp. - January 19, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it has received a $250,000 Letter of Commitment for funding from the McGill University Health Centre (MUHC) Foundation. The Letter of Commitment confirms that the MUHC Foundation will...
Biotechnology, Pharmaceuticals, Health
2023-01-19 11:28 AM EST | Hemostemix Inc. -
Lobe Sciences Provides Update For 2023 Milestones
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering and developing patient focused psychedelic derived medicines for neurologic and brain disease today announced an updated overview for 2023.Mr. Philip Young, Chairman...
Technology, Pharmaceuticals, Health
2023-01-18 7:00 AM EST | Lobe Sciences Ltd. -
Advanced Proteome Therapeutics Announces Its Proposed Plan of Arrangement
Burnaby, British Columbia--(Newsfile Corp. - January 17, 2023) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") is pleased to announce that the Supreme Court of British Columbia (the "Court") has issued an interim order (the "Interim Order") on January 16, 2023 in connection with the...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2023-01-17 2:39 PM EST | Advanced Proteome Therapeutics Corp. -
GoodCap Announces the Appointment of Dr. Laura Targownik to Its Scientific Advisory Board
Toronto, Ontario--(Newsfile Corp. - January 17, 2023) - GoodCap Pharmaceuticals Inc. ("GoodCap" or the "Company"), is pleased to announce the appointment of Dr. Laura Targownik, MD, to its Scientific Advisory Board.Dr. Targownik is currently a Clinician Researcher in the Mount Sinai Hospital Inflammatory Bowel Disease Clinic and is a member...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2023-01-17 9:00 AM EST | GoodCap Pharmaceuticals Inc. -
Shockwave Medical to Acquire Neovasc
Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the treatment of refractory angina, announced today that the Company has entered into a binding agreement (the "Arrangement Agreement") with Shockwave...
Pharmaceuticals, Health
2023-01-17 8:27 AM EST | Neovasc Inc. -
BioHarvest Sciences Inc. Appoints Dr. George Garibaldi to Its Scientific Board of Advisors
Dr. Garibaldi's 40 years of experience brings industry-leading pharmaceuticals development expertise to the Scientific Board of Advisors.His appointment demonstrates the company's resolve to leverage its biotechnology platform for enabling drugs development.Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 17, 2023) - BioHarvest Sciences Inc. (CSE:
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Cultivator
2023-01-17 7:30 AM EST | BioHarvest Sciences Inc.